These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24524332)

  • 1. Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.
    Wesseling H; Guest PC; Lago SG; Bahn S
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1327-41. PubMed ID: 24524332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Studies of Psychiatric Disorders.
    Guest PC
    Methods Mol Biol; 2018; 1735():59-89. PubMed ID: 29380307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Sampling and Preparation Procedures for Proteomic Biomarker Studies of Psychiatric Disorders.
    Guest PC; Rahmoune H
    Adv Exp Med Biol; 2017; 974():141-147. PubMed ID: 28353230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders.
    Rahmoune H; Martins-de-Souza D; Guest PC
    Adv Exp Med Biol; 2017; 974():69-84. PubMed ID: 28353225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.
    Pieragostino D; Petrucci F; Del Boccio P; Mantini D; Lugaresi A; Tiberio S; Onofrj M; Gambi D; Sacchetta P; Di Ilio C; Federici G; Urbani A
    J Proteomics; 2010 Jan; 73(3):579-92. PubMed ID: 19666151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting.
    Bouwman FG; de Roos B; Rubio-Aliaga I; Crosley LK; Duthie SJ; Mayer C; Horgan G; Polley AC; Heim C; Coort SL; Evelo CT; Mulholland F; Johnson IT; Elliott RM; Daniel H; Mariman EC
    BMC Med Genomics; 2011 Mar; 4():24. PubMed ID: 21439033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric disorders biochemical pathways unraveled by human brain proteomics.
    Saia-Cereda VM; Cassoli JS; Martins-de-Souza D; Nascimento JM
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):3-17. PubMed ID: 27377417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Human Brain Proteome Project: Biological and Technological Challenges.
    Fernández-Irigoyen J; Corrales F; Santamaría E
    Methods Mol Biol; 2019; 2044():3-23. PubMed ID: 31432403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
    Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
    J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
    Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
    Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Selected Reaction Monitoring Mass Spectrometry Protocol for Validation of Proteomic Biomarker Candidates in Studies of Psychiatric Disorders.
    Reis-de-Oliveira G; Garcia S; Guest PC; Cassoli JS; Martins-de-Souza D
    Adv Exp Med Biol; 2017; 974():213-218. PubMed ID: 28353238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of Multiplex Assays for Identification of Proteomic Signatures in Psychiatry.
    Chen J; Guest PC; Schwarz E
    Adv Exp Med Biol; 2017; 974():131-138. PubMed ID: 28353229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders.
    Sarnyai Z; Guest PC
    Adv Exp Med Biol; 2017; 974():97-114. PubMed ID: 28353227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS
    Fioramonte M; Guest PC; Martins-de-Souza D
    Adv Exp Med Biol; 2017; 974():115-129. PubMed ID: 28353228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic research in psychiatry.
    Taurines R; Dudley E; Grassl J; Warnke A; Gerlach M; Coogan AN; Thome J
    J Psychopharmacol; 2011 Feb; 25(2):151-96. PubMed ID: 20142298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling proteoforms: promising follow-up of proteomics for biomarker discovery.
    Lisitsa A; Moshkovskii S; Chernobrovkin A; Ponomarenko E; Archakov A
    Expert Rev Proteomics; 2014 Feb; 11(1):121-9. PubMed ID: 24437377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.